MISSION Therapeutics
Series BMISSION Therapeutics raised €24M in a Series B round in Nov 2013. The company is based in Cambridge, UK. Investors in the round: Roche Venture Fund, Sofinnova Partners. Data as of 4 Nov 2026.
Amount raised
€24M
€23,523,877
Native amount
20,000,000 GBP
Stage
Series B
series b
Investors
2
Provenance & confidence
UnverifiedAmount
20,000,000 GBP
ECB-at-date → €24M · rate 0.8502 on 2013-10-31
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Nov 2013
Round type
series b
Amount (EUR)
€24M